BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
March 29, 2016
View Archived Issues
Inactivating variants in ANGPTL4 are associated with lower risk of coronary artery disease
Read More
Prosaposin-derived therapeutic cyclic peptide promotes tumor regression in ovarian cancer models
Read More
Bayer receives Japanese approval for Xofigo
Read More
Japanese approval for Kovaltry
Read More
ABHD2 as a new target for developing male contraceptives
Read More
New ursolic acid derivatives are effective as potential anti-inflammatory treatment
Read More
ORIG3N and Sharp Edge Labs establish drug discovery alliance
Read More
Redx Pharma patents Raf kinase inhibitors
Read More
GlaxoSmithKline discloses HUNK1 inhibitors
Read More
Hong Kong Polytechnic University develops antibacterial agents
Read More
Landsteiner Genmed reports compounds for the treatment of fat accumulation
Read More
Janssen R&D Ireland presents anti-influenza agents
Read More
The potential of dispiro-cycloalkanone compounds as antifilarial drug candidates
Read More
Regeneron and Bayer to jointly develop nesvacumab/aflibercept combination for eye diseases
Read More
Alder reports results from two trials of ALD-403 for migraine prevention
Read More
FDA issues complete response letter for Brintellix sNDA
Read More
Nucala approved in Japan
Read More
Ubenimex awarded orphan drug designation in E.U. for PAH
Read More
Kamada submits MAA for inhaled AAT therapy to treat AAT deficiency
Read More
Dr. Reddy's gains U.S. rights to Xenoport's XP-23829
Read More
Iterum licenses rights to novel anti-infective compound, secures series A financing
Read More
Phase III trials of encenicline for cognitive impairment in schizophrenia miss primary endpoints
Read More
Kanuma approved in Japan to treat patients with lysosomal acid lipase deficiency
Read More
CA4P given E.U. orphan status for treating neuroendocrine tumors
Read More
Imbruvica approved in Japan for chronic lymphocytic leukemia
Read More
AstraZeneca receives Japanese approval for Tagrisso
Read More
New dose and formulation of Malarone combination tablets receive Japanese approval
Read More
Novartis reports Japanese approval of Tafinlar and Mekinist
Read More